Trending Topic

3 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

We are delighted to present the latest edition of touchREVIEWS in Oncology & Haematology. This issue underscores the evolving landscape of cancer therapeutics, showcasing advances across a wide range of malignancies, from haematologic diseases to solid tumours, through novel mechanisms, emerging biomarkers and personalized treatment strategies. We begin with an editorial by Isabela Wen-Chi Chang […]

Naval Daver, ASH 2019: Venetoclax in Combination with Idasanutlin in Relapsed or Refractory AML

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Dec 18th 2019

At the 61st ASH Annual Meeting & Exposition, Naval Daver, MD Anderson Cancer Center, discusses his presentation: Updated Results from the Venetoclax (Ven) in Combination with Idasanutlin (Idasa) Arm of a Phase 1b Trial in Elderly Patients (Pts) with Relapsed or Refractory (R/R) AML Ineligible for Cytotoxic Chemotherapy.

Questions

1. What are the current therapeutic options for elderly patients with relapsed or refractory AML ineligible for chemotherapy? (0:05)

2. Could you tell us a little about the mechanism of action of idasanutlin? (1:24)

3. What is the rationale for the combination of venetoclax and idasanutlin? (2:50)

4. Could you tell us a little about the phase 1b study and its efficacy and safety findings? (4:36)

5. What progress has been made in identifying biomarkers of response to this combined therapy? (6:30)

 

Naval Daver has received consulting fees from Abbvie, Genentech, BMS, PFizer, Forty-Seven, DAiichi Sankyo, Astellas, Celgene and Novartis. He has received research funding from Abbvie, Genentech, BMS, PFizer, Forty-Seven, DAiichi Sankyo, Astellas, Celgene and Novartis.

Filmed at the 61st ASH Annual Meeting & Exposition 2019, Orlando, FL, USA.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup